Heranova Lifesciences Debuts with $13.5 Million Seed and Seed+ Round Funding to Offer Integrated Clinical Solutions to Women's Health
- Written by PR Newswire
BOSTON and HONG KONG, Dec. 28, 2023 /PRNewswire/ -- Heranova Lifesciences Holding Ltd. ("Heranova") today announced the successful completion of a USD 13.5 million seed and seed+ financing to develop and offer integrated Women's Health solutions worldwide. This funding will be used to launch a serial of non-invasive endometriosis tests and...














